Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22298660)

  • 21. Safety of capecitabine: a review.
    Mikhail SE; Sun JF; Marshall JL
    Expert Opin Drug Saf; 2010 Sep; 9(5):831-41. PubMed ID: 20722491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-reported compliance with capecitabine: findings from a prospective cohort analysis.
    Winterhalder R; Hoesli P; Delmore G; Pederiva S; Bressoud A; Hermann F; von Moos R;
    Oncology; 2011; 80(1-2):29-33. PubMed ID: 21606661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
    Aprile G; Mazzer M; Moroso S; Puglisi F
    Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation.
    Ward S; Kaltenthaler E; Cowan J; Brewer N
    Health Technol Assess; 2003; 7(32):1-93. PubMed ID: 14604497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer.
    Kusama M; Nomizu T; Aogi K; Yoshimoto M; Horikoshi N; Tabei T; Noguchi S; Miura S; Yoshimura N; Kimura M; Toyama K; Shin E
    Breast Cancer; 2010 Oct; 17(4):233-40. PubMed ID: 19633909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on capecitabine alone and in combination regimens in colorectal cancer patients.
    Silvestris N; Maiello E; De Vita F; Cinieri S; Santini D; Russo A; Tommasi S; Azzariti A; Numico G; Pisconti S; Petriella D; Lorusso V; Millaku A; Colucci G
    Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S46-55. PubMed ID: 21129610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy and safety of regimens of capecitabine-based chemotherapy in the treatment of advanced breast cancer].
    Huang HY; Jiang ZF; Wang T; Zhang SH; Bian L; Cao Y; Wu SK; Song ST
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):850-3. PubMed ID: 22335952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer.
    Lortholary A; Hardy-Bessard AC; Bachelot T; de Rauglaudre G; Alexandre J; Bourgeois H; Jaubert D; Paraiso D; Largillier R
    Breast Cancer Res Treat; 2012 Jan; 131(1):127-35. PubMed ID: 21947680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertriglyceridaemia-induced pancreatitis: a contributory role of capecitabine?
    Chan HY; Ng CM; Tiu SC; Chan AO; Shek CC
    Hong Kong Med J; 2012 Dec; 18(6):526-9. PubMed ID: 23223655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients].
    Yamaguchi T; Fukuda M; Yasui H; Okazaki S; Kubo K; Tanaka M; Une Y; Setoguchi Y; Hanada K; Moriyama S; Tani M; Murakami T; Okuchi Y; Ogiso S; Hata H; Sakata S; Otani T; Yamato T; Ikai I
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):389-93. PubMed ID: 22421765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumors.
    Dennie TW; Fleming RA; Bowen CJ; Dar MM; Alberti D; Oliver K; Loconte N; Mulkerin D; Holen KD
    Clin Colorectal Cancer; 2011 Mar; 10(1):57-62. PubMed ID: 21609937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capecitabine-induced severe hypertriglyceridemia: report of two cases.
    Kurt M; Babaoglu MO; Yasar U; Shorbagi A; Guler N
    Ann Pharmacother; 2006 Feb; 40(2):328-31. PubMed ID: 16391007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer chemotherapy and cardiovascular risks: is capecitabine-induced hypertriglyceridemia a rare adverse effect?
    Seminara P; Losanno T; Emiliani A; Manna G
    Cardiology; 2010; 116(1):42-4. PubMed ID: 20431291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palmar-plantar erythrodysesthesia associated with scrotal and penile involvement with capecitabine.
    Sapp CM; DeSimone P
    Clin Colorectal Cancer; 2007 Jan; 6(5):382-5. PubMed ID: 17311704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature.
    Hennessy BT; Gauthier AM; Michaud LB; Hortobagyi G; Valero V
    Ann Oncol; 2005 Aug; 16(8):1289-96. PubMed ID: 15890665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of capecitabine in first-line treatment for patients with metastatic breast cancer.
    Gelmon K; Chan A; Harbeck N
    Oncologist; 2006; 11 Suppl 1():42-51. PubMed ID: 16971739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer.
    Deenen MJ; Tol J; Burylo AM; Doodeman VD; de Boer A; Vincent A; Guchelaar HJ; Smits PH; Beijnen JH; Punt CJ; Schellens JH; Cats A
    Clin Cancer Res; 2011 May; 17(10):3455-68. PubMed ID: 21498394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of capecitabine in cancer: management of the hand foot syndrome.
    Sudoyo AW
    Acta Med Indones; 2005; 37(3):174-6. PubMed ID: 16110178
    [No Abstract]   [Full Text] [Related]  

  • 39. Capecitabine-induced pancreatitis.
    Jones KL; Valero V
    Pharmacotherapy; 2003 Aug; 23(8):1076-8. PubMed ID: 12921254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer.
    Di Seri M; De Sanctis R; Quadrini S; Adua D; Stumbo L; Del Signore E; Gori B; Grassi P; Basile ML; Longo F
    J Chemother; 2011 Apr; 23(2):110-3. PubMed ID: 21571629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.